$60.02
1.121.90%
At close: -
$59.93
-0.09-0.15%
After Hours: 6:54 PM EDT
Comments
Loading...
Bristol-Myers Squibb Stock Guidance | NYSE:BMY | Benzinga
Bristol-Myers Squibb issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/06/2025 | BMY | Bristol-Myers Squibb | FY | 2025 | $6.55 | $6.85 | $6.92 | $45.50B | $45.50B | $46.27B | Get Alert |
| 10/31/2024 | BMY | Bristol-Myers Squibb | FY | 2024 | $0.75 | $0.95 | $0.71 | $47.26B | $47.26B | $46.78B | Get Alert |
| 07/26/2024 | BMY | Bristol-Myers Squibb | FY | 2024 | $0.60 | $0.90 | $0.51 | — | — | — | Get Alert |
| 04/25/2024 | BMY | Bristol-Myers Squibb | FY | 2024 | $0.40 | $0.70 | $0.65 | — | — | — | Get Alert |
| 02/02/2024 | BMY | Bristol-Myers Squibb | FY | 2024 | $7.10 | $7.40 | $7.00 | — | — | — | Get Alert |
| 10/26/2023 | BMY | Bristol-Myers Squibb | FY | 2023 | $7.50 | $7.65 | $7.36 | — | — | — | Get Alert |
| 07/27/2023 | BMY | Bristol-Myers Squibb | FY | 2023 | $7.35 | $7.65 | $7.99 | — | — | — | Get Alert |
| 04/27/2023 | BMY | Bristol-Myers Squibb | FY | 2023 | $7.95 | $8.25 | $8.06 | $47.08B | $47.08B | $46.84B | Get Alert |
| 02/02/2023 | BMY | Bristol-Myers Squibb | FY | 2023 | $7.95 | $8.25 | $8.00 | $47.08B | $47.08B | $47.15B | Get Alert |
| 10/25/2022 | BMY | Bristol-Myers Squibb | FY | 2022 | $7.44 | $7.74 | $7.52 | $46.00B | $46.00B | $45.97B | Get Alert |
| 07/27/2022 | BMY | Bristol-Myers Squibb | FY | 2022 | $7.44 | $7.74 | $7.46 | $46.00B | $46.00B | $46.24B | Get Alert |
| 04/29/2022 | BMY | Bristol-Myers Squibb | FY | 2022 | $7.44 | $7.74 | $7.73 | — | — | — | Get Alert |
| 02/04/2022 | BMY | Bristol-Myers Squibb | FY | 2022 | $7.65 | $7.95 | $7.86 | — | — | — | Get Alert |
| 01/10/2022 | BMY | Bristol-Myers Squibb | FY | 2022 | $7.65 | $7.95 | $7.84 | $47.00B | $47.00B | $47.75B | Get Alert |
| 10/27/2021 | BMY | Bristol-Myers Squibb | FY | 2021 | $7.40 | $7.55 | $7.47 | — | — | — | Get Alert |
| 07/28/2021 | BMY | Bristol-Myers Squibb | FY | 2021 | $7.35 | $7.55 | $7.46 | — | — | — | Get Alert |
| 04/29/2021 | BMY | Bristol-Myers Squibb | FY | 2021 | $7.35 | $7.55 | $7.48 | — | — | — | Get Alert |
| 02/04/2021 | BMY | Bristol-Myers Squibb | FY | 2021 | $7.35 | $7.55 | $7.45 | — | — | — | Get Alert |
| 11/05/2020 | BMY | Bristol-Myers Squibb | FY | 2020 | $6.25 | $6.35 | $6.27 | $41.50B | $42.00B | $41.96B | Get Alert |
| 11/05/2020 | BMY | Bristol-Myers Squibb | FY | 2021 | $7.15 | $7.45 | — | — | — | — | Get Alert |
| 08/06/2020 | BMY | Bristol-Myers Squibb | FY | 2020 | $6.10 | $6.25 | $6.20 | $40.50B | $42.00B | $41.90B | Get Alert |
FAQ
What is the most recent guidance for Bristol-Myers Squibb (BMY)?
The most recent guidance for Bristol-Myers Squibb (BMY) was reported on February 6, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $6.55 to $6.85, compared to the estimated EPS of $6.92. Additionally, Bristol-Myers Squibb forecasted revenue between $45.50B and $45.50B for the quarter.
Browse guidance and forecast on all stocks.